The present invention relates to the identification of the H37 tumor suppressor gene and methods of diagnosing and treating a disease or disorder characterized by abnormal cellular proliferation, such as a tumor or cancer. Diagnosis is accomplished examining or monitoring cells for perturbations in H37 expression or function. Treatment is accomplished by inserting a host cell compatible H37 expression vector or an effective amount of H37 protein into a cell or cells in need of treatment.